Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy

Di Maio VC;Barbaliscia S;Teti E;Lenci I;Aragri M;Polilli E;Gianserra L;Palitti VP;Bruzzone B;Paolucci S;Coppola N;Ruggiero T;Pollicino T;Niero F;Micheli V;Di Biagio A;Bertoli A;Sticchi L;Maida I;Francioso S;Foroghi L;Calvaruso V;Morisco F;Lleo A;Ciancio A;Maserati R;Brancaccio G;Puoti M;Toniutto P;Vullo V;Aghemo A;Cariti G;Bonora S;Babudieri S;Gubertini GA;Rendina M;Pellicelli AM;Sangiovanni V;Ciaccio A;Taliani G;Raimondo G;Craxi A;Pasquazzi C;Sarmati L;Parruti G;Angelico M;Andreoni M;Cento V;Perno CF;Ceccherini-Silberstein F

2017-01-01